Wissenschaftliche Mitarbeiter

Dr. rer. nat. Bianca Kollhorst

Lebenslauf

  • 2003-2008: Studium der Mathematik (Diplom) an der Universität Oldenburg
  • 2008: Erfolgreicher Abschluss des Mathematikstudiums
  • 2008-2010: Statistikerin bei der SCIderm GmbH Hamburg
  • Seit Dezember 2010: Wissenschaftliche Mitarbeiterin am BIPS
  • Seit Oktober 2015: Fachgruppenleiterin der Fachgruppe Statistische Modellierung von Sekundär- und Registerdaten

Mitgliedschaft in Fachgesellschaften

Projekte

Ausgewählte Veröffentlichungen

  • Zeitschriftenartikel mit peer-review

  • March S, Antoni M, Kieschke J, Kollhorst B, Maier B, Müller G, Sariyar M, Schulz M, Swart E, Zeidler J, Hoffmann F. Quo vadis Datenlinkage in Deutschland? Eine erste Bestandsaufnahme. Das Gesundheitswesen. 2018;80(3):e20-e31.
    http://dx.doi.org/10.1055/s-0043-125070
  • Jobski K, Kollhorst B, Garbe E, Schink T. The risk of ischemic cardio- and cerebrovascular events associated with oxycodone/naloxone and other extended-release high-potency opioids: A nested case-control study. Drug Safety. 2017;40(6):505-515.
    http://dx.doi.org/10.1007/s40264-017-0511-8
  • Jobski K, Schmedt N, Kollhorst B, Krappweis J, Schink T, Garbe E. Characteristics and drug use patterns of older antidepressant initiators in Germany. European Journal of Clinical Pharmacology. 2017;73(1):105-113.
    http://dx.doi.org/10.1007/s00228-016-2145-7
  • Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann R, Garbe E, Riedel O. Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011. European Child & Adolescent Psychiatry. 2017;26(4):413-420.
    http://dx.doi.org/10.1007/s00787-016-0905-7
  • Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann R, Garbe E, Riedel O. Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011. Pharmacoepidemiology and Drug Safety. 2017;26(2):170-179.
    http://dx.doi.org/10.1002/pds.4138
  • Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann R, Garbe E, Riedel O. Extent and risks of antipsychotic off-label use in children and adolescents in Germany between 2004 and 2011. Journal of Child and Adolescent Psychopharmacology. 2017;27(9):806-813.
    https://doi.org/10.1089/cap.2016.0202
  • Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann R, Garbe E, Riedel O. Extent and risks of antidepressant off-label use in children and adolescents in Germany between 2004 and 2011. Pharmacoepidemiology and Drug Safety. 2017;26(11):1395-1402.
    http://dx.doi.org/10.1002/pds.4289
  • Thöne K, Kollhorst B, Schink T. Non-steroidal anti-inflammatory drug use and the risk of acute myocardial infarction in the general German population: A nested case-control study. Drugs - Real World Outcomes. 2017;4(3):127-137.
    https://doi.org/10.1007/s40801-017-0113-x
  • Arfè A, Scotti L, Varas-Lorenzo C, Nicotra F, Zambon A, Kollhorst B, Schink T, Garbe E, Herings R, Straatman H, Schade R, Villa M, Lucchi S, Valkhoff VE, Romio S, Thiessard F, Schuemie M, Pariente A, Sturkenboom MCJM, Corrao G, on behalf of the SOS project consortium. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: Nested case-control study. British Medical Journal. 2016;354:i4857.
    http://dx.doi.org/10.1136/bmj.i4857
  • Douros A, Jobski K, Kollhorst B, Schink T, Garbe E. Risk of venous thromboembolism in cancer patients treated with epoetins or blood transfusions. British Journal of Clinical Pharmacology. 2016;82(3):839-848.
    http://dx.doi.org/10.1111/bcp.13019
  • Enders D, Kollhorst B, Engel S, Linder R, Verheyen F, Pigeot I. Comparative risk for cardiovascular diseases of dipeptidyl peptidase-4 inhibitors vs. sulfonylureas in combination with metformin: Results of a two-phase study. Journal of Diabetes and its Complications. 2016;30(7):1339-1346.
    http://dx.doi.org/10.1016/j.jdiacomp.2016.05.015
  • Kollhorst B, Abrahamowicz M, Pigeot I. The proportion of all previous patients was a potential instrument for patients' actual prescriptions of nonsteroidal anti-inflammatory drugs. Journal of Clinical Epidemiology. 2016;69:96-106.
    http://dx.doi.org/10.1016/j.jclinepi.2015.08.008
  • Schmedt N, Jobski K, Kollhorst B, Krappweis J, Schink T, Rüther E, Garbe E. Treatment patterns and characteristics of older antipsychotic users in Germany. International Clinical Psychopharmacology. 2016;31(3):159-169.
    http://dx.doi.org/10.1097/YIC.0000000000000119
  • Schmedt N, Kollhorst B, Enders D, Jobski K, Krappweis J, Garbe E, Schink T. Comparative risk of death in older adults treated with antipsychotics: A population-based cohort study. European Neuropsychopharmacology. 2016;26(9):1390-1400.
    http://dx.doi.org/10.1016/j.euroneuro.2016.07.006
  • Jobski K, Kollhorst B, Schink T, Garbe E. The risk of opioid intoxications or related events and the effect of alcohol-related disorders: A retrospective cohort study in German patients treated with high-potency opioid analgesics. Drug Safety. 2015;38(9):811-822.
    http://dx.doi.org/10.1007/s40264-015-0312-x
  • Kollhorst B, Behr S, Enders D, Dippel F-W, Theobald K, Garbe E. Comparison of basal insulin therapies with regard to the risk of acute myocardial infarction in patients with type 2 diabetes: An observational cohort study. Diabetes, Obesity & Metabolism. 2015;17(12):1158-1165.
    http://dx.doi.org/10.1111/dom.12554
  • Dissertation

  • Kollhorst B. Controlling for unobserved confounders in observational studies using large health care databases by means of instrumental variables in time-to-event analysis. Bremen: Universität Bremen; 2017.
    http://nbn-resolving.de/urn:nbn:de:gbv:46-00105848-17.
  • Vorträge bei wissenschaftlichen Tagungen

  • Kollhorst B, Abrahamowicz M, Pigeot I. Evaluation of the two-stage residual inclusion method for instrumental variable estimation in survival analysis: A simulation study. 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 25-28 August 2016, Dublin, Ireland.
  • Kollhorst B, Garbe E, Pigeot I. Application of instrumental variable analysis to administrative data of statutory health insurances: Potential and limitations. 60. Biometrisches Kolloquium der Deutschen Region der Internationalen Biometrischen Gesellschaft (IBS-DR), 10.-13. März 2014, Bremen.
  • Kollhorst B, Schink T, Arfè A, Herings R, Lucchi S, Nicotra F, Romio S, Schade R, Schuemie M, Straatman H, Thiessard F, Valkhoff VE, Villa M, Varas-Lorenzo C, Sturkenboom MCJM, Garbe E. Risk of ischemic stroke associated with the use of individual non-steroidal anti-inflammatory drugs. 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 23-26 August 2012, Barcelona, Spain. (Abstract published in: Pharmacoepidemiology & Drug Safety. 2012;21(Suppl.3):180)
  • Poster bei wissenschaftlichen Tagungen

  • Kollhorst B, Garbe E. Is the physician's preference a valid instrumental variable in the German Pharmacoepidemiological Research Database? 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 25-28 August 2013, Montreal, Canada.
  • Behr S, Kollhorst B, Dippel F-W, Garbe E. Identification of patients with diabetes mellitus type 2 in insurance claims data - Are problems caused by ambiguous ICD-10 codes? 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 23-26 August 2012, Barcelona, Spain. (Abstract published in: Pharmacoepidemiology & Drug Safety. 2012;21(Suppl.3):396)

Weitere Publikationen finden Sie unter nachfolgendem Link:

Verantwortlich für den Inhalt dieser Seite ist Bianca Kollhorst.